Wilkins J, Leedom J M, Salvatore M, Portnoy B
Calif Med. 1972 Dec;117(6):12-7.
The responses of seven hpv-77 rubella vaccinees to initial challenge with "wild" rubella virus have been compared with their responses to rechallenge with Brown strain rubella virus and to the responses of five "natural" immunes to initial Brown strain challenge. Previous exposure to "wild" rubella virus 220 days post vaccine-induced immunity had resulted in six of the seven vaccinees experiencing asymptomatic reinfection. On "rechallenge" none of the previously "reinfected vaccine immunes" demonstrated clinical, virologic or serologic evidence of reinfection. These data are consistent with the conclusion that persons with vaccine-induced immunity may be assured of more prolonged and solid immunity to rubella without having to suffer the clinical disease if they are reinfected with nonattenuated rubella virus. Rigidly controlled experiments, designed to study the practicality and safety of immunization with live rubella vaccine(s), followed by deliberate challenge of vaccinees with "wild" or low tissue culture passage rubella virus, seem warranted. In addition, these data indicate that it is imperative that a distinction should be made between "vaccine immunes" and previously "reinfected vaccine immunes" in any evaluation of long term rubella vaccine(s) efficacy and vaccine-induced antibody decay.
已将7名接种HPV - 77风疹疫苗者对“野生”风疹病毒初次攻击的反应,与其对布朗株风疹病毒再次攻击的反应以及5名“自然”免疫者对布朗株初次攻击的反应进行了比较。在疫苗诱导免疫220天后,先前接触过“野生”风疹病毒,导致7名疫苗接种者中有6人经历了无症状再感染。在“再次攻击”时,先前“再感染的疫苗免疫者”均未表现出再感染的临床、病毒学或血清学证据。这些数据与以下结论一致:具有疫苗诱导免疫力的人,如果再次感染未减毒的风疹病毒,可能无需患临床疾病就能获得更持久、更稳固的风疹免疫力。似乎有必要进行严格对照的实验,以研究接种活风疹疫苗的实用性和安全性,然后有意用“野生”或低组织培养传代风疹病毒攻击疫苗接种者。此外,这些数据表明,在评估长期风疹疫苗效力和疫苗诱导抗体衰减时,必须区分“疫苗免疫者”和先前“再感染的疫苗免疫者”。